- Report
- January 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- November 2023
- 144 Pages
Global
From €2401EUR$2,499USD£2,053GBP
- Report
- October 2023
- 181 Pages
Global
From €4708EUR$4,900USD£4,025GBP
Lamisil is an antifungal medication used to treat a variety of fungal infections, including those caused by dermatophytes, yeasts, and molds. It is commonly used to treat infections of the skin, nails, and scalp, as well as fungal infections of the mouth, throat, and lungs. Lamisil is part of the Infectious Diseases Drugs market, which includes medications used to treat a variety of bacterial, viral, and fungal infections. These drugs are used to treat a wide range of infections, from minor skin infections to life-threatening illnesses.
The Infectious Diseases Drugs market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. Other companies in the market include Bayer, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more